Abstract and Introduction
Abstract
Consistent with other studies, depression improved with this collaborative intervention; cardiac outcomes improved too, but this novel finding was based on a relatively small number of patients and events.
Introduction
In cardiac patients with depression, cardiac outcomes (i.e., recurrent cardiac events and mortality) are worse than in nondepressed cardiac patients; several large studies have shown that treating depression reduces depressive symptoms and improves quality of life, but rarely improves cardiac outcomes. In a randomized, controlled, 6-month trial, 157 patients with acute coronary syndromes (ACSs) and persistent (>3 months) depressive symptoms received a depression intervention or usual care. The collaborative, "stepped-care" intervention differed from previous interventions in allowing patients to choose problem-solving therapy, antidepressants, or both, as well as to switch, add, or adjust treatment, depending on response, at 8-week intervals. The researchers also followed a cohort of 80 nondepressed ACS patients.
At 6 months, intervention patients were significantly more likely than usual-care patients to receive antidepressant medication (48% vs. 30%) or psychotherapy (39% vs. 12%) and had greater improvements in depression (moderate-to-large effect size of 0.59) and more satisfaction with depression care (54% vs. 19%). Intervention patients also had significantly fewer major adverse cardiac events (4% vs. 13%), with an event rate similar to that seen in nondepressed controls (6%).
Journal Watch © 2010 Massachusetts Medical Society
Cite this: Depression Treatment for Patients with Acute Coronary Syndromes - Medscape - May 01, 2010.
Comments